Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
150 participants
OBSERVATIONAL
2015-11-30
2018-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interpersonal Therapy-Based Treatment to Prevent Postpartum Depression in Adolescent Mothers
NCT00436150
Effects of Interpersonal Psychotherapy on Depression During and After Pregnancy
NCT00380419
Relationship Between Postpartum Mood Disorders and Delivery Experience
NCT03004872
Depression Prevention for Pregnant Women on Public Assistance
NCT00601757
Perinatal Thymic DYsregulation: Characterization of Perinatal Mood Episodes
NCT07008183
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Remitted Major Depression Group
Women in this group will have experienced at least one episode of major depression in their lifetime, but no episodes in the two months prior to study enrollment.
No interventions assigned to this group
Control Group
Women in this group will never have experienced any Diagnostic and Statistical Manual of Mental Disorders, 5th Edition Axis I psychological disorder.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Female
* Currently pregnant - approximately no more than 34 weeks gestational age
* Able to read and write in English fluently
* MDD Group: Meet DSM-IV/DSM-5 criteria for at least 1 past episode of Major Depressive Disorder
* MDD Group: DO NOT meet DSM-IV/DSM-5 criteria for any episodes of Major Depressive Disorder in past 2 months (currently in symptom remission)
Exclusion Criteria
* Imminently suicidal or homicidal
* History of severe head trauma, stroke, neurological disease
* History of brain tumors or surgery
* Severe medical illness (e.g., autoimmune disorder, blindness, cardiovascular disease, HIV/AIDS)
* Endocrine disorders (e.g., Cushing's disease, thyroid disorder)
* Alcohol/substance abuse or dependence within the past six months
* Current psychotic episode (impairing ability to consent, participate, or keep patient and experimenter safe)
* Inability to follow study procedures
* CTL Group: Current or lifetime Axis I disorder (i.e., anxiety disorders, major depression, mania/hypomania, dysthymia, schizophrenia, schizoaffective disorder, substance abuse/dependence, eating disorders, hypochondriasis, pain disorder, or adjustment disorders)
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
John Templeton Foundation
OTHER
Emory University
OTHER
University of Michigan
OTHER
Columbia University
OTHER
Queen's University
OTHER
University of Colorado, Boulder
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sona Dimidjian
Professor and Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sona Dimidjian, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Colorado, Boulder
June Gruber, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Colorado, Boulder
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Colorado Boulder
Boulder, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
49683
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.